Photo Credit: IANS

IANSLive

New York, April 12 (IANS) A new personalised cancer vaccine, developed by the US researchers, is safe and beneficial for patients with different cancers, including lung and bladder, results of phase I clinical trials have shown.

To get full access of the story, click here to subscribe to IANS News Service

© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.

For news, views and gossips, follow IANS at Twitter.

Update: 12-April-2021